Cargando…
The therapeutic response of somatotropinomas according to the T2-weighted signal intensity on the MRI
BACKGROUND AND AIM: Identifying the predictive factors of tumoral and hormonal answer of somatotropinomas to the medical treatment with somatostatin analogs represent an important element for treatment management. The aim of this study was to assess the therapeutic answer of the somatotropinomas acc...
Autores principales: | Scânteie, Carla-Liana, Leucuţa, Daniel-Corneliu, Ghervan, Cristina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iuliu Hatieganu University of Medicine and Pharmacy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389873/ https://www.ncbi.nlm.nih.gov/pubmed/36105498 http://dx.doi.org/10.15386/mpr-1299 |
Ejemplares similares
-
Imatinib Inhibits GH Secretion From Somatotropinomas
por: Gupta, Prakamya, et al.
Publicado: (2018) -
The immune microenviroment in somatotropinomas: from biology to personalized and target therapy
por: Chiloiro, Sabrina, et al.
Publicado: (2023) -
Association between radiological parameters and clinical and molecular characteristics in human somatotropinomas
por: Alhambra-Expósito, María R., et al.
Publicado: (2018) -
ZAC1 and SSTR2 Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas
por: Vieria Neto, Leonardo, et al.
Publicado: (2013) -
Correction: ZAC1 and SSTR2 Are Downregulated in Non-Functioning Pituitary Adenomas but Not in somatotropinomas
por: Vieira Neto, Leonardo, et al.
Publicado: (2013)